Preparation procedures for drugs containing these modules, as well as procedures for the treatment of acute respiratory retransmission, metabolic and autoimmune diseases. 1. Claim 1: a formula compound (1),O select R1 from group H as agent or acceptable salt of c8332123 asphalt；C₁₋₃ alkoxy,Cf8323 and halo； R,R³ and R⁴ are H； R⁵ is C₁₋₃ alkyl；R⁶ is C₃₋₅ alkyl or -CH₂-C₃₋₄ cycloalkyl；R8311 was selected from formula residues (2) and (3) groups；each R⁸ is independently selected from the group consisting of halo, C₁₋₆ alkyl,C₁₋₆ alkoxy,C₃₋₆ cycloalkyl,CN, OH, C (O) OH, C (O) O-C₁₋₃ alkyl and CH₂OH； R⁹ is the group - (CHR¹⁰) ₛ- (X) ₜ- (CHR¹⁰) ᵘ-R¹¹；Each r83044 is independent of H, ch8323；Oh, and ch8322； Oh, X is ch832222,NH or O； R¹¹ is a heterocycloalkyl or C₃₋₆ cycloalkyl group which may not be substituted or substituted with one or more substituents independently selected from the group consisting of CH₃,Ome, oh, ch8322；； oh and halo； R is 0, 1 or 2； s is 0, 1 or 2； t is 0 or 1； u is 0, 1 or 2； provided that there are no more than two groups representing ch832304；Oh, o.c83228ohProcedimientos para su preparación, composiciones farmacéuticas que contienen estos modulares y a su uso en el tratamiento de enfermedades inflamatorias, metabólicas y autoinmunitarias mediadas por el RORg. Reivindicación 1: Un compuesto de fórmula (1), o una sal farmacéuticamente aceptable del mismo, en la que R¹ se selecciona del grupo constituido por H, alquilo C₁₋₃, alcoxi C₁₋₃, CF₃ y halo； R², R³ y R⁴ son H； R⁵ es alquilo C₁₋₃； R⁶ es alquilo C₃₋₅ o -CH₂-cicloalquilo C₃₋₄； R⁷ se selecciona del grupo constituido por los restos de fórmula (2) y (3)； cada R⁸ se selecciona independientemente del grupo constituido por halo, alquilo C₁₋₆, alcoxi C₁₋₆, cicloalquilo C₃₋₆, CN, OH, C(O)OH, C(O)O-alquilo C₁₋₃ y CH₂OH； R⁹ es el grupo -(CHR¹⁰)ₛ-(X)ₜ-(CHR¹⁰)ᵘ-R¹¹； cada R¹⁰ se selecciona independientemente de entre H, CH₃, OH y CH₂OH； X es CH₂, NH u O； R¹¹ es un grupo heterocicloalquilo o cicloalquilo C₃₋
